Suppr超能文献

HEP-Net关于在巴基斯坦资源有限环境下失代偿期肝硬化患者腹水及其并发症管理的意见。

HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.

作者信息

Ali Bushra, Salim Adnan, Alam Altaf, Zuberi Bader Faiyaz, Ali Zeeshan, Azam Zahid, Kamani Lubna, Farooqi Javed Iqbal, Salih Muhammed, Nawaz Arif Amir, Chaudhry Asad Ali, Hashmi Zahid Yasin, Siddique Masood

机构信息

Bushra Ali, Fatima Memorial Medical and Dental College, Lahore, Pakistan.

Adnan Salim, Shaikh Zayed Postgraduate Medical Institute, Lahore, Pakistan.

出版信息

Pak J Med Sci. 2020 Jul-Aug;36(5):1117-1132. doi: 10.12669/pjms.36.5.2407.

Abstract

Approximately one half of patients develop ascites within 10 years of diagnosis of compensated cirrhosis. It is a poor prognostic indicator, with only 50% surviving beyond two years. Mortality worsens significantly to 20% to 50% at one year if the ascites becomes refractory to medical therapy. Pakistan has one of the highest prevalence of viral hepatitis in the world and patients with ascites secondary to liver cirrhosis make a major percentage of both inpatient and outpatient burden. Studies indicate that over 80% of patients admitted with ascites have liver cirrhosis as the cause. This expert opinion suggests proper assessment of patients with ascites in the presence of underlying cirrhosis. This expert opinion includes appropriate diagnosis and management of uncomplicated ascites, refractory ascites and complicated ascites (including spontaneous bacterial peritonitis (SBP) ascites, hepatorenal syndrome (HRS) and hyponatremia. The purpose behind this expert opinion is to help consultants, postgraduate trainees, medical officers and primary care physicians optimally manage their patients with cirrhosis and ascites in a resource constrained setting as is often encountered in a developing country like Pakistan.

摘要

约一半的患者在代偿期肝硬化确诊后的10年内会出现腹水。它是一个预后不良的指标,只有50%的患者能存活超过两年。如果腹水对药物治疗产生耐药,一年的死亡率会显著恶化至20%至50%。巴基斯坦是世界上病毒性肝炎患病率最高的国家之一,肝硬化继发腹水的患者在住院和门诊负担中占很大比例。研究表明,超过80%因腹水入院的患者病因是肝硬化。本专家意见建议对存在潜在肝硬化的腹水患者进行恰当评估。本专家意见包括对单纯性腹水、顽固性腹水和复杂性腹水(包括自发性细菌性腹膜炎(SBP)腹水、肝肾综合征(HRS)和低钠血症)进行适当的诊断和管理。本专家意见的目的是帮助会诊医生、研究生学员、医务人员和初级保健医生,在像巴基斯坦这样的发展中国家经常遇到的资源有限的情况下,对肝硬化和腹水患者进行最佳管理。

相似文献

3
Management of ascites and hepatorenal syndrome.腹水和肝肾综合征的管理。
Hepatol Int. 2018 Feb;12(Suppl 1):122-134. doi: 10.1007/s12072-017-9815-0. Epub 2017 Aug 23.
4
Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians.肝硬化腹水的优化管理:内科医师综述
J Transl Int Med. 2020 Dec 31;8(4):220-236. doi: 10.2478/jtim-2020-0035. eCollection 2020 Dec.
7
Presentation and complications associated with cirrhosis of the liver.肝硬化的临床表现及相关并发症。
Curr Med Res Opin. 2015 May;31(5):925-37. doi: 10.1185/03007995.2015.1021905.

本文引用的文献

9
Diagnosis and management of renal dysfunction in patients with cirrhosis.肝硬化患者肾功能障碍的诊断和治疗。
Expert Rev Gastroenterol Hepatol. 2020 Jan;14(1):1-7. doi: 10.1080/17474124.2020.1708190. Epub 2019 Dec 30.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验